BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 7001837)

  • 1. The influence of supervision and endogenous insulin secretion on the course of insulin-dependent diabetes mellitus.
    Deckert T
    Acta Endocrinol Suppl (Copenh); 1980; 238():31-8. PubMed ID: 7001837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The prognosis of insulin-dependent diabetes mellitus].
    Deckert T
    Z Gesamte Inn Med; 1981 Jan; 36(1):4-8. PubMed ID: 7013293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent insulin secretion, assessed by plasma C-peptide estimation in long-term juvenile diabetics with a low insulin requirement.
    Eff C; Faber O; Deckert T
    Diabetologia; 1978 Sep; 15(3):169-72. PubMed ID: 359394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum C-peptide concentrations poorly phenotype type 2 diabetic end-stage renal disease patients.
    Covic AM; Schelling JR; Constantiner M; Iyengar SK; Sedor JR
    Kidney Int; 2000 Oct; 58(4):1742-50. PubMed ID: 11012908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin secretion in non-obese (J-type) diabetics in Papua New Guinea.
    Martin FI; Simeanova L
    Aust N Z J Med; 1979 Jun; 9(3):260-2. PubMed ID: 111657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognosis of insulin dependent diabetes mellitus and the importance of supervision.
    Deckert T; Poulsen JE; Larsen M
    Acta Med Scand Suppl; 1979; 624():48-53. PubMed ID: 106628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual insulin secretion in adolescent diabetics after remission.
    Hocking MD; Rayner PW; Nattrass M
    Arch Dis Child; 1987 Nov; 62(11):1144-7. PubMed ID: 3318713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-year follow-up study of C-peptide secretion in newly diagnosed type I diabetics: relations to HLA-phenotype, insulin requirement and metabolic control.
    Rjasanowski I; Michaelis D; Keilacker H; Besch W; Richter KV; Heinke P
    Exp Clin Endocrinol; 1987 Apr; 89(2):216-24. PubMed ID: 3301371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-peptide in juvenile diabetics beyond the postinitial remission period. Relation to clinical manifestations at onset of diabetes, remission and diabetic control.
    Ludvigsson J; Heding LG; Larsson Y; Leander E
    Acta Paediatr Scand; 1977 Mar; 66(2):177-84. PubMed ID: 402787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The remission stage in juvenile diabetes].
    Buysschaert M; Ketelslegers JM; Van Halle B; Lambert AE
    Acta Clin Belg; 1980; 35(5):293-9. PubMed ID: 7013394
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of health resort treatment on insulin and C-peptide concentration in girls with insulin-dependent diabetes.
    Bonikowska-Zgaińska M
    Mater Med Pol; 1996; 28(4):115-31. PubMed ID: 9308334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Insulin resistance and insulin secretion in type II non-obese diabetics].
    Pelikánová T; Válek J; Kazdová L; Saudek F; Karasová L
    Cas Lek Cesk; 1994 Mar; 133(6):172-6. PubMed ID: 8156572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test: methodological aspects and clinical applications.
    Scheen AJ; Castillo MJ; Lefèbvre PJ
    Diabetes Metab; 1996 Dec; 22(6):397-406. PubMed ID: 8985647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoreactive gastric inhibitory polypeptide response to a meal during the first eighteen months after diagnosis of type 1 (insulin dependent) diabetes mellitus.
    Krarup T; Madsbad S; Moody AJ
    J Clin Endocrinol Metab; 1985 Jan; 60(1):120-5. PubMed ID: 3880559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon-C-peptide test as a measure of insulin requirement in type 2 diabetes: evaluation of stopping insulin therapy in eleven patients.
    Viikari J; Rönnemaa T; Koskinen P
    Ann Clin Res; 1987; 19(3):178-82. PubMed ID: 3314647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Residual insulin secretion in juvenile diabetes. Relationships with duration of diabetes, metabolic control and retinopathy (author's transl)].
    Dorchy H; Despontin M; Haumont D; Toussaint D; Loeb H
    Arch Fr Pediatr; 1982 Mar; 39(3):145-8. PubMed ID: 7049110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous plasma insulin in a juvenile diabetic after ten years of insulin therapy.
    Johansen K
    Arch Intern Med; 1971 Jan; 127(1):139-40. PubMed ID: 5538984
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum magnesium in insulin-dependent diabetics and healthy subjects in relation to insulin secretion and glycemia during glucose-glucagon test.
    Menzel R; Pusch H; Ratzmann GW; Besch W; Förster F; Albrecht G; Ruhnke R
    Exp Clin Endocrinol; 1985 Feb; 85(1):81-8. PubMed ID: 3886415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Catecholamine excretion in diabetics on insulin treatment].
    Koev D; Ovcharova N; Kamenova P; Iankova G; Lefterova P
    Vutr Boles; 1990; 29(4):34-40. PubMed ID: 2281657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of hyperbaric oxygenation on residual insulin secretion in patients with diabetes mellitus type 1].
    Dedov II; Lukich VL; Bol'shakova TD; Gitel' EP; Dreval' AV
    Probl Endokrinol (Mosk); 1987; 33(4):10-5. PubMed ID: 3309933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.